The Y in Psychiatry

Late Life Depression: When the Golden Years Turn Grey (and the SSRIs Don't Shine)

18 min · 28 de mar de 2025
Portada del episodio Late Life Depression: When the Golden Years Turn Grey (and the SSRIs Don't Shine)

Descripción

Send us Fan Mail [https://www.buzzsprout.com/2185312/fan_mail/new] It never gets old to talk about late-life depression. Lets explore why growing older can sometimes mean growing sadder. We prance through executive dysfunction, vascular woes, inflammatory fires, and amyloid beta blues.  We’ll discuss why SSRIs might not be the golden ticket and what alternatives, like dopamine agonists, rTMS, and even ECT, can brighten those grey years. Plus, we'll ponder if your patient is depressed, or if their brain is just throwing a vascular tantrum. Tune in, turn up your hearing aids, and fluid restrict for the next 20 minutes if you have the worlds smallest bladder. https://www.nguyenindoubt.com/theyinpsych https://feeds.buzzsprout.com/2185312.rss

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de The Y in Psychiatry!

Prueba gratis

Empieza 7 días de prueba

$99 / mes después de la prueba. · Cancela cuando quieras.

  • Podcasts solo en Podimo
  • 20 horas de audiolibros al mes
  • Podcast gratuitos

Todos los episodios

21 episodios

episode Cobenfy Unleashed: Psychiatry's New Frontier artwork

Cobenfy Unleashed: Psychiatry's New Frontier

Send us Fan Mail [https://www.buzzsprout.com/2185312/fan_mail/new] Cobenfy doesn't block dopamine — and that's the whole point. In this special episode, we step away from the bipolar just a bit to unpack the first genuinely new mechanism in schizophrenia treatment in decades. We break down how Cobenfy pairs xanomeline (a brain-penetrant M1/M4 muscarinic agonist) with trospium (a peripheral blocker that curbs the side effects), trace its surprising betel-nut origins, and explain the why behind the how: quieting dopamine in the striatum for positive symptoms and boosting GABA in the prefrontal cortex for cognition — all without the D2 blockade that brings EPS, weight gain, and sedation. https://www.nguyenindoubt.com/theyinpsych https://feeds.buzzsprout.com/2185312.rss

6 de jun de 202620 min
episode Late Life Depression: When the Golden Years Turn Grey (and the SSRIs Don't Shine) artwork

Late Life Depression: When the Golden Years Turn Grey (and the SSRIs Don't Shine)

Send us Fan Mail [https://www.buzzsprout.com/2185312/fan_mail/new] It never gets old to talk about late-life depression. Lets explore why growing older can sometimes mean growing sadder. We prance through executive dysfunction, vascular woes, inflammatory fires, and amyloid beta blues.  We’ll discuss why SSRIs might not be the golden ticket and what alternatives, like dopamine agonists, rTMS, and even ECT, can brighten those grey years. Plus, we'll ponder if your patient is depressed, or if their brain is just throwing a vascular tantrum. Tune in, turn up your hearing aids, and fluid restrict for the next 20 minutes if you have the worlds smallest bladder. https://www.nguyenindoubt.com/theyinpsych https://feeds.buzzsprout.com/2185312.rss

28 de mar de 202518 min